McKesson Reports Fiscal 2022 Fourth Quarter and Full-Year Results
Fourth-Quarter Highlights: (Source: McKesson News)
Source: McKesson News - May 5, 2022 Category: Information Technology Source Type: news
Distributors Agree to Opioid Settlement with Washington State
CONSHOHOCKEN, Pa.& DUBLIN, Ohio& IRVING, Texas, May 3, 2022 —(BUSINESS WIRE)—AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518... (Source: McKesson News)
Source: McKesson News - May 3, 2022 Category: Information Technology Source Type: news
McKesson Declares Quarterly Dividend
IRVING, Texas, April 28, 2022 -- The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on July 1, 2022, to stockholders of record on June 1, 2022. (Source: McKesson News)
Source: McKesson News - April 28, 2022 Category: Information Technology Source Type: news
McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
IRVING, Texas, April 7, 2022 —McKesson Corporation (NYSE: MCK) today announced that it has closed the transaction announced in November 2021 to sell its UK businesses to AURELIUS. This is another important step in advancing McKesson’s commitment to streamline the business and fully exit the European ... (Source: McKesson News)
Source: McKesson News - April 7, 2022 Category: Information Technology Source Type: news
McKesson ’s Board of Directors Elects W. Roy Dunbar as New Director
IRVING, Texas, April. 1, 2022 – McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022. With the election of Dunbar, McKesson’s board of directors increases... (Source: McKesson News)
Source: McKesson News - April 1, 2022 Category: Information Technology Source Type: news
VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson
CARY, N.C., March 14, 2022 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by CTI BioPharma Corp. as a specialty pharmacy provider for VONJOTM (pacritinib) for the treatment of intermediate or high-risk primary or secondary (pos... (Source: McKesson News)
Source: McKesson News - March 14, 2022 Category: Information Technology Source Type: news
McKesson Supports Ukraine Relief Efforts
IRVING, Texas, March 14, 2022 – McKesson plays a critical role in building a healthier future for everyone and has a history of supporting people around the world when it’s needed the most. (Source: McKesson News)
Source: McKesson News - March 14, 2022 Category: Information Technology Source Type: news
PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson
CARY, N.C., March 2, 2022 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Agios Pharmaceuticals, Inc. as a specialty pharmacy provider for PYRUKYND® (mitapivat) for the treatment of hemolytic anemia in adults with pyruvate ki... (Source: McKesson News)
Source: McKesson News - March 2, 2022 Category: Information Technology Source Type: news
Distributors Approve Opioid Settlement Agreement
CONSHOHOCKEN, PA.& DUBLIN, Ohio& IRVING, Texas, Feb. 25, 2022 — (BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that each company has independently determined that there is sufficient participation by states and litigating polit... (Source: McKesson News)
Source: McKesson News - February 25, 2022 Category: Information Technology Source Type: news
McKesson Designated by CMS as 2022 Qualified Clinical Data Registry
IRVING, Texas, Feb. 8, 2022 — For the sixth consecutive year, McKesson has received approval from The Centers for Medicare& Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). The designation enables iKnowMed ℠ elect... (Source: McKesson News)
Source: McKesson News - February 8, 2022 Category: Information Technology Source Type: news
Ontada Names Dr. Nicholas Robert as Chief Medical Officer
IRVING, TEXAS — Ontada®, a McKesson business focused on oncology provider technology solutions, targeted channels for biopharmaceutical and provider engagement, and a research arm focused on clinical data and evidence solutions, announced the promotion of Nicholas Robert, M.D., to the role of Chief... (Source: McKesson News)
Source: McKesson News - February 7, 2022 Category: Information Technology Source Type: news
McKesson Reports Fiscal 2022 Third Quarter-Results
Third-Quarter Highlights, Year-over-Year: (Source: McKesson News)
Source: McKesson News - February 2, 2022 Category: Information Technology Source Type: news
McKesson Recognized as one of the “Best Places to Work for LGBTQ+ Equality” for Ninth Year in a Row
IRVING, Texas, Jan. 27, 2022 —For the ninth consecutive year, McKesson Corporation is honored as one of the “Best Places to Work for LGBTQ+ Equality” by the Human Rights Campaign (HRC) Foundation. McKesson achieved 100 percent on the HRC’s 2022 Corporate Equality Index (CEI), a nationally recognized ... (Source: McKesson News)
Source: McKesson News - January 27, 2022 Category: Information Technology Source Type: news
McKesson Declares Quarterly Dividend
IRVING, Texas, January 27, 2022 —The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on April 1, 2022, to stockholders of record on March 1, 2022. (Source: McKesson News)
Source: McKesson News - January 27, 2022 Category: Information Technology Source Type: news
Ontada Names Viraj Narayanan as Chief Commercial Officer
IRVING, TEXAS, Jan. 25, 2022 —Ontada®, a McKesson business focused on oncology provider technology solutions, targeted channels for biopharmaceutical and provider engagement, and a research arm focused on clinical data and evidence solutions, announced today the appointment of Viraj Narayanan as Chie... (Source: McKesson News)
Source: McKesson News - January 25, 2022 Category: Information Technology Source Type: news
